Blind ? [Two-Stage / GS Designs]

posted by Ohlbe – France, 2010-10-27 23:37  – Posting: # 6092
Views: 9,227

Dear Jack,

What's probably confusing to a number of people following this thread is what you exactly mean with "blind". In clinical trials this is usually meant as not knowing which treatment is administered to which patient/subject. In a BE trial this usually only applies to the bioanalytical lab. You can't run the statistical analysis without unblinding (even if you call the products A and B and don't tell the statistician which is the test and which is the reference, it won't make any difference).

So to keep it short, a question from a non-statistician: what do you exactly mean by blinded in this particular context ? Blinded to what ?

Regards
Ohlbe

Regards
Ohlbe

Complete thread:

Activity
 Admin contact
20,128 posts in 4,245 threads, 1,384 registered users;
online 17 (0 registered, 17 guests [including 7 identified bots]).
Forum time (Europe/Vienna): 23:03 CET

You really don’t know what you don’t know until you write about it.
Then, everyone knows what you don’t know.    Rod Machado

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5